DE

Germany

28776 clinical trials

Find Trials

Clinical Trials (28776)

Showing 20 of 28,776 trialsScroll for more
NCT06806592Phase 318 sites

A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases

Active Not Recruiting
NCT07153471Phase 313 sites

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Active Not Recruiting
NCT06291376Phase 310 sites

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Active Not Recruiting
NCT06079879Phase 33 sites

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

Active Not Recruiting
NCT06307652Phase 334 sites

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Recruiting
NCT07680764Phase 26 sites

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Recruiting
NCT06623422Phase 38 sites

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Recruiting
NCT04575961Phase 22 sites

Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer

Active Not Recruiting
NCT02720952Phase 31 site

Treatment of Adrenal Insufficiency in Children

Completed
NCT05319730Phase 14 sites

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Recruiting
NCT04585750Phase 15 sites

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Recruiting
NCT0547692625 sites

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Active Not Recruiting
NCT06780098Phase 22 sites

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

Recruiting

Met Non Small Cell Cancer Registry (MOMENT)

Recruiting
NCT06796907Phase 14 sites

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

Recruiting
NCT04408638Phase 33 sites

A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Active Not Recruiting
NCT07440225Phase 22 sites

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Recruiting
NCT06956235Phase 22 sites

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

Active Not Recruiting

Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study

Completed

A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma

Recruiting